The prevalence and associated distress of physical and psychological symptoms in patients with advanced heart failure attending a south African medical center

Journal of Cardiovascular Nursing

Volumn 31, Issue 4, 2016, Pages 313-322

  Lokker, Martine E ^a,b   Gwyther, Liz ^b   Riley, Jillian P ^c   Van Zuylen, Lia ^a   Van Der Heide, Agnes ^a   Harding, Richard ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

advanced heart failure; palliative care; symptoms

Indexed keywords

AFFECT; COMPLICATION; FEMALE; HEART FAILURE; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; NEW YORK; PAIN; PREVALENCE; PSYCHOLOGY; QUALITY OF LIFE;

AFFECT; FEMALE; HEART FAILURE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; NEW YORK; PAIN; PREVALENCE; QUALITY OF LIFE;

EID: 84976400691     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0000000000000256     Document Type: Article

References (70)

1. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 292(3): 344-350.
2. Levy D, Kenchaiah S, Larson MG, et al. Long-Term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18): 1397-1402.
3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33(14): 1787-1847.
4. Howlett JG. Palliative care in heart failure: addressing the largest care gap. Curr Opin Cardiol. 2011; 26(2): 144-148.
5. Nordgren L, Sorensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs. 2003; 2(3): 213-217.
6. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000; 83(5): 596-602.
7. Petrie M, McMurray J. Changes in notions about heart failure. Lancet. 2001; 358(9280): 432-434.
8. Gadoud A, Jenkins SM, Hogg KJ. Palliative care for people with heart failure: summary of current evidence and future direction. Palliat Med. 2013; 27(9): 822-828.
9. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL. Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage. 2008; 35(6): 594-603.
10. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ?malignant than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001; 3(3): 315-322.
11. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam Study. Eur Heart J. 2004; 25(18): 1614-1619.
12. Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000; 83(5): 505-510.
13. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J AmColl Cardiol. 1993; 22(4 suppl A): 6AY13A.
14. The British Society for Heart Failure. National Heart Failure Audit. London, England: National Institute for Cardiovascular Outcomes Research (NICOR); 2012.
15. Stewart S, Ekman I, Ekman T, Oden A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes. 2010; 3(6): 573-580.
16. Jhund PS, Macintyre K, Simpson CR, et al. Long-Term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009; 119(4): 515-523.
17. Strachan PH, Ross H, Rocker GM, Dodek PM, Heyland DK, Canadian Researchers at the End of LifeNetwork.Mind the gap: opportunities for improving end-of-life care for patients with advanced heart failure. Can J Cardiol. 2009; 25(11): 635-640.
18. Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J. 2002; 23(11): 877-885.
19. Kruse W. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1991; 39(10): 1045-1046.
20. Bekelman DB, Havranek EP, Becker DM, et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007; 13(8): 643-648.
21. Bekelman DB, Rumsfeld JS, Havranek EP, et al. Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med. 2009; 24(5): 592-598.
22. Benedict CR, Weiner DH, Johnstone DE, et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. JAmCollCardiol. 1993; 22(4 suppl A): 146AY153A.
23. Goebel JR, Doering LV, Shugarman LR, et al. Heart failure: the hidden problem of pain. J Pain Symptom Manage. 2009; 38(5): 698-707.
24. Janssen DJ, Spruit MA, Wouters EF, Schols JM. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med. 2008; 22(8): 938-948.
25. Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-Termdeclines in health status in patients with heart failure. J Am Coll Cardiol. 2003; 42(10): 1811-1817.
26. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-Analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006; 48(8): 1527-1537.
27. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005; 4(3): 198-206.
28. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative care in the treatment of advanced heart failure. Circulation. 2009; 120(25): 2597-2606.
29. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J. 1998; 19(suppl P): P9YP16.
30. McMurray JJ, Stewart S. The burden of heart failure. Eur Heart J Suppl. 2002; 4(suppl D): D50YD58.
31. Ntusi NB, Mayosi BM. Epidemiology of heart failure in sub-Saharan Africa. Exp Rev Cardiovasc Ther. 2009; 7(2): 169-180.
32. Statistics South Africa. Mortality and causes of death in South Africa, 2010: findings from death notification. Pretoria. 2013. http://www.statssa.gov.za/publications/p03093/.p030932010.pdf. Accessed February 26, 2015.
33. Amoah AG, Kallen C. Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology. 2000; 93(1-2): 11-18.
34. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012; 379(9819): 953-964.
35. WHO. Rheumatic Fever and Rheumatic Heart Disease: Report of aWHO Expert Consultation. Geneva, Switzerland: World Health Organization; 2004.
36. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949: 196.
37. Schaafsma J, Osoba D. The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res. 1994; 3(6): 413-424.
38. Brezinski D, Stone PH, Muller JE, et al. Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance: theMILIS Study Group. Am Heart J. 1991; 121(5): 1374-1381.
39. Johnson MJ, Bland JM, Davidson PM, et al. The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale. J Pain Symptom Manage. 2014; 47(3): 652-658.
40. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer. 1984; 53(9): 2002-2007.
41. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984; 2(3): 187-193.
42. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980; 45(8): 2220-2224.
43. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. TheMemorial Symptom Assessment Scale Short Form(MSAS-SF). Cancer. 2000; 89(5): 1162-1171.
44. Bekelman DB, Nowels CT, Allen LA, Shakar S, Kutner JS, Matlock DD. Outpatient palliative care for chronic heart failure: a case series. J Palliat Med. 2011; 14(7): 815-821.
45. Harding R, Selman L, Agupio G, et al. Prevalence, burden, and correlates of physical and psychological symptoms among HIVpalliative care patients in sub-Saharan Africa: an international multicenter study. J Pain Symptom Manage. 2012; 44(1): 1-9.
46. Harding R, Selman L, Agupio G, et al. The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries. Eur J Cancer. 2011; 47(1): 51-56.
47. Chang VT, Hwang SS, Thaler HT, Kasimis BS, Portenoy RK. Memorial symptom assessment scale. Exp Rev Pharmacoecon Outcomes Res. 2004; 4(2): 171-178.
48. Song EK, Moser DK, Rayens MK, Lennie TA. Symptom clusters predict event-free survival in patients with heart failure. J Cardiovasc Nurs. 2010; 25(4): 284-291.
49. Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013; 16(1): 87-90.
50. Kirkova J, Rybicki L, Walsh D, Aktas A. Symptom prevalence in advanced cancer: age, gender, and performance status interactions. Am J Hosp Palliat Care. 2012; 29(2): 139-145.
51. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1, 000 patients. Support Care Cancer. 2000; 8(3): 175-179.
52. The National Department of Health, Republic of South Africa. Standard Treatment Guidelines and Essential Medicines List Primary Health Care. Pretoria, South Africa: The National Department of Health; 2008.
53. The National Department of Health, Republic of South Africa. Standard Treatment Guidelines and Essential Medicines List for South Africa Hospital Level Adults. Pretoria, South Africa: The National Department of Health; 2012.
54. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis andManagement ofHeart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119(14): 1977-2016.
55. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012; 14(8): 803-869.
56. Janssen DJ, Spruit MA, Uszko-Lencer NH, Schols JM, Wouters EF. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med. 2011; 14(6): 735-743.
57. Rutten FH, Heddema WS, Daggelders GJ, Hoes AW. Primary care patients with heart failure in the last year of their life. Fam Pract. 2012; 29(1): 36-42.
58. Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW. Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J. 2010; 160(1): 139-144.
59. Son YJ, Lee Y, Song EK. Adherence to a sodium-restricted diet is associated with lower symptom burden and longer cardiac event-free survival in patients with heart failure. J Clin Nurs. 2011; 20(21-22): 3029-3038.
60. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003; 42(7): 1226-1233.
61. Tevendale E, Baxter J. Heart failure comorbidities at the end of life. Curr Opin Support Palliat Care. 2011; 5(4): 322-326.
62. Borne Y, Engstrom G, Essen B, Sundquist J, Hedblad B. Country of birth and risk of hospitalization due to heart failure: a Swedish population-based cohort study. Eur J Epidemiol. 2011; 26(4): 275-283.
63. Benderly M, Haim M, Boyko V, Goldbourt U. Socioeconomic status indicators and incidence of heart failure among men and women with coronary heart disease. J Card Fail. 2013; 19(2): 117-124.
64. Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012; 14(2): 138-146.
65. Harris B, Goudge J, Ataguba JE, et al. Inequities in access to health care in South Africa. J Public Health Policy. 2011; 32(suppl 1): S102YS123.
66. Sauerborn R, Adams A, Hien M. Household strategies to cope with the economic costs of illness. Soc Sci Med. 1996; 43(3): 291-301.
67. Godfrey C, Harrison MB, Medves J, Tranmer JE. The symptom of pain with heart failure: a systematic review. J Card Fail. 2006; 12(4): 307-313.
68. Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009; 11(5): 433-443.
69. Johnson MJ, Booth S. Palliative and end-of-life care for patients with chronic heart failure and chronic lung disease. Clin Med. 2010; 10(3): 286-289.
70. Lemond L, Allen LA. Palliative care and hospice in advanced heart failure. Prog Cardiovasc Dis. 2011; 54(2): 168-178.